TrialMediators of inflammation2012

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Carlos Gonzalez-Juanatey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.